NCT01243658

"The Effects of Oxytocin on Patients With Borderline Personality Disorder"

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 138 (actual)
• Sponsor: Prof. Dr. Markus Heinrichs · Academic / Other
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

RCT. Two substudies (clinical and experimental). Main objective of the trial is to examine if oxytocin, compared to placebo shows any additional effect on the therapy achievements (outcome) of patients with borderline personality disorder, who receive an in-patient standard psychotherapy (Dialectical-behavioral-therapy, Marsha Linehan (2006)). Secondary objectives : Investigate if oxytocin compared to placebo enhances social trust and emotion recognition in patients with borderline personality disorder. Comparison of the effects of Oxytocin on patients with BPD and major depression.

Conditions

• Effects of Oxytocin on Borderline Personality Disorder
• Borderline Personality Disorder

Interventions

Type	Name	Description
DRUG	Oxytocin	Oxytocin
OTHER	placebo	placebo

Timeline

• Start date: 2011-01-01
• Primary completion: 2021-04-01
• Completion: 2022-04-01
• First posted: 2010-11-18
• Last updated: 2022-11-03

Locations

1 site across 1 country: Germany